Nonspecific amine-binding sites (NSABS)

Nonspecific amine-binding sites (NSABS) are high-capacity, relatively nonspecific pharmacological sites in the brain and other tissues that exhibit high affinity for lipophilic amines. They are best known as the primary target for the SPECT imaging agent N-isopropyl-p-iodoamphetamine (IMP), where their presence allows for the prolonged retention of the tracer in brain tissue [2, 4]. While their exact molecular identity remains a subject of research, they are often characterized as amine-binding receptors and are distinct from specific neurotransmitter receptors [4, 8]. These sites are highly expressed in certain malignancies, most notably Primary Central Nervous System Lymphoma (PCNSL), as well as melanoma and bronchial carcinoid tumors [4, 11]. In clinical practice, the interaction between IMP and these sites is exploited in delayed SPECT imaging to differentiate PCNSL from other brain lesions, as PCNSL typically shows significantly higher delayed uptake compared to glioblastomas or meningiomas [4, 8]. Recent pharmacological studies suggest that these sites may overlap with Sigma-1 and Sigma-2 receptors, which are known to bind a wide variety of amine-containing drugs [17, 18].

Other names

Amine-binding receptorsHigh-capacity amine binding sitesNonspecific amine receptorsIMP binding sitesNonspecific amine-binding sites in brain tissue

High-affinity, high-capacity binding to lipophilic amines, leading to slow washout and prolonged retention in tissues with high site density [2, 8, 9].